The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prognostic impact of dose, duration, and timing of corticosteroid therapy in patients with large B-cell lymphoma treated with standard of care axicabtagene ciloleucel (Axi-cel).
 
Paolo Strati
No Relationships to Disclose
 
fateeha furqan
No Relationships to Disclose
 
Jason Westin
Consulting or Advisory Role - Amgen; Celgene; Curis; Genentech/Abbvie; Janssen Scientific Affairs; Juno Therapeutics; Juno Therapeutics; Kite/Gilead; MorphoSys; Novartis
Research Funding - Bristol-Myers Squibb; Celgene; Curis; Genentech; Janssen; Kite/Gilead; Novartis
 
Luis Fayad
No Relationships to Disclose
 
Sairah Ahmed
Honoraria - Adaptive Biotechnologies
Research Funding - Merck (Inst); Seagen (Inst)
 
Hun Ju Lee
Consulting or Advisory Role - Bristol-Myers Squibb; Guidepoint Global
Research Funding - Bristol-Myers Squibb; Celgene; Celgene; Oncternal Therapeutics; Seagen; Takeda
 
Swaminathan Padmanabhan Iyer
Research Funding - Arog (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Genentech/Roche (Inst); Incyte (Inst); Novartis (Inst); Takeda (Inst)
 
Ranjit Nair
No Relationships to Disclose
 
Loretta J. Nastoupil
Honoraria - Bayer; Celgene; Gamida Cell; Gilead Sciences; Janssen Oncology; Juno Therapeutics; Novartis; Pfizer; Spectrum Pharmaceuticals; TG Therapeutics
Research Funding - Celgene; Genentech/Roche; Janssen Biotech; Karus Therapeutics; LAM Therapeutics; TG Therapeutics
 
Simrit Parmar
Stock and Other Ownership Interests - cellenkos; cellenkos (Inst)
Research Funding - cellenkos (Inst)
 
Maria Alma Rodriguez
Research Funding - Amgen (Inst); GlaxoSmithKline (Inst); Ortho Biotech (Inst); Pfizer (Inst)
 
Felipe Samaniego
No Relationships to Disclose
 
Raphael Steiner
No Relationships to Disclose
 
Michael Wang
Stock and Other Ownership Interests - More Health
Honoraria - AstraZeneca; Dava Oncology; Janssen Research & Development; OM Pharmaceutical Industries; Onclive; oncology business review; Peerview; Pharmacyclics; Targeted Oncology
Consulting or Advisory Role - AstraZeneca; AxImmune; Bioinvent; Celgene; Guidepoint Global; Janssen Research & Development; Juno Therapeutics; Kite, a Gilead company; Loxo; More Health; Noble Insights; Pharmacyclics/Janssen; Pulse Biosciences
Research Funding - Acerta Pharma; Amgen; AstraZeneca; BeiGene; Bioinvent; Celgene; Janssen Research & Development; Juno Therapeutics; Kite, a Gilead company; Loxo; Novartis; Oncternal Therapeutics; Pharmacyclics; VelosBio; Verastem
Travel, Accommodations, Expenses - AstraZeneca; Celgene; Dava Oncology; Janssen Research & Development; OM Pharmaceutical Industries
 
Chelsea Camille Pinnix
Employment - MD Anderson Cancer Center
Stock and Other Ownership Interests - Neumentum (I)
Honoraria - International Journal of Radiation Oncology Biology Physics
Research Funding - Merck
Travel, Accommodations, Expenses - Merck
 
Christopher Flowers
Consulting or Advisory Role - Abbvie; AstraZeneca; Bayer; BeiGene; Celgene; Denovo Biopharma; Genentech/Roche; Gilead Sciences; Karyopharm Therapeutics; MEI Pharma; Pharmacyclics/Janssen; Spectrum Pharmaceuticals
Research Funding - Abbvie (Inst); Acerta Pharma (Inst); BeiGene (Inst); Celgene (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Immune Design (Inst); Janssen Oncology (Inst); Millennium (Inst); Onyx (Inst); Pharmacyclics (Inst); TG Therapeutics (Inst)
Travel, Accommodations, Expenses - Celgene; Genentech/Roche; Gilead Sciences
 
Sandra B. Horowitz
No Relationships to Disclose
 
Catherine Classen
No Relationships to Disclose
 
Haleigh Mistry
No Relationships to Disclose
 
Sattva Swarup Neelapu
Honoraria - Aptitude Health; Bio Ascend; Medscape; MJH Life Sciences
Consulting or Advisory Role - Alimera Sciences; Celgene; Cell Medica; Gilead Sciences; Incyte; Kite, a Gilead company; Legend Biotech; Merck Sharp & Dohme; Novartis; Pfizer; Precision Biosciences; Unum Therapeutics
Research Funding - Acerta Pharma; Alimera Sciences; Bristol-Myers Squibb; Cellectis; Gilead Sciences; Karus Therapeutics; Kite, a Gilead company; Merck Sharp & Dohme; poseida therapeutics; Precision Biosciences; Unum Therapeutics
Patents, Royalties, Other Intellectual Property - Patents related to cellular therapy
Travel, Accommodations, Expenses - Alimera Sciences; Celgene; Chugai Pharma; Kite/Gilead; Legend Biotech; Medscape; Merck; Novartis; Pfizer; Precision Biosciences; Unum Therapeutics